by LIVIUS Editorial | Dec 7, 2025 | Research Update
LIVIUS continues to advance its cellular reprogramming platform based on miRNA biology, small-molecule epigenetic control, and DNA repair mechanisms. Current efforts are focused on strengthening platform robustness and supporting early discovery and preclinical...
